This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Boston Beer Stands Out From Alcohol-Beverage Peers
by Zacks Equity Research
Boston Beer (SAM) gains from momentum in shipment volume and depletion, driven by its three-point growth plan. This places it ahead of peers in an otherwise struggling alcohol industry.
Here's Why You Must Hold on to Molson Coors Stock Despite Woes
by Zacks Equity Research
Molson Coors (TAP) witnesses soft volume in the United States and higher input costs resulting from tough industry conditions. But the company's premiumization and cost-saving efforts hold potential.
Why Is Molson Coors (TAP) Down 8.6% Since Last Earnings Report?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Beverages - Alcohol Industry Trends Suggest Growth in the Future
by Rajani Lohia
The alcohol space looks poised for growth as premium and innovative beverages are gaining traction. Meanwhile, cannabis drinks provide a lucrative opportunity for growth.
Buy Marijuana Stocks, Tilray & Aurora Cannabis, Before Earnings?
by Benjamin Rains
The legal marijuana industry is still in the early stages, so let's see if investors should consider buying some pure-play marijuana stocks heading into earnings.
Company News For May 2, 2019
by Zacks Equity Research
Companies in the news are: AAPL, CVS, TAP and RCL
Molson Coors Brewing (TAP) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Molson Coors (TAP) delivered earnings and revenue surprises of -8.77% and -0.56%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Molson Coors (TAP) Stock Falls on Q1 Earnings & Sales Miss
by Zacks Equity Research
Molson Coors' (TAP) top and bottom lines miss estimates in first-quarter 2019, driven by soft volume, offset by higher pricing.
Molson Coors (TAP) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Molson Coors (TAP) to gain from improved pricing, International strength and cost savings in first-quarter 2019. Soft North America volume, input cost inflation and currency headwinds may persist.
Molson Coors Brewing (TAP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molson Coors Launches Two Beer Brands Online in Singapore
by Zacks Equity Research
Molson Coors' (TAP) Carling and Blue Moon brands are now available off-premise in Singapore through Amazon Prime Now.
Will Craft Brewers Mar Beer Industry's Fortunes?
by Nitish Marwah
Prudent marketing strategies and acquisition of smaller brewers in the country have paid off for the bigger players.
No China Deal Yet, but Equities Rally Anyway.
by David Borun
The broad markets add roughly another 2% during a quiet but steady week.
3 Reasons Why You Must Hold on to Boston Beer (SAM) Stock
by Zacks Equity Research
Boston Beer (SAM) witnesses strength from momentum in shipment volumes and strong depletions. However, soft trends in the Samuel Adams brand and higher costs remain headwinds.
Molson Coors (TAP) Up 1.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Investors Need to Know About Investing in Marijuana Stocks
by Benjamin Rains
Let's look at what investors need to know about the marijuana industry and how to invest in the future of pot.
ETFs and Stocks to Tap the Marijuana Boom
by Sweta Killa
First it was bitcoin that made investors go on a mad rush, and today, it's marijuana. Now that legalization is steadily gaining traction across the U.S., more investors than ever before are looking for ways to cash in.
4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
by Sanghamitra Saha
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.
Company News For Feb 13, 2019
by Zacks Equity Research
Companies in the news are: UAA, TAP, SHOP and CHGG
Molson Coors (TAP) Q4 Earnings Beat, Soft Volume Hurts Sales
by Zacks Equity Research
Positive pricing, strength in Europe and International, and cost savings aid Molson Coors' (TAP) Q4 earnings. Soft global brand volume due to weak demand in the United States and Canada hurts sales.
Molson Coors Brewing (TAP) Beats Q4 Earnings Estimates
by Zacks Equity Research
Molson Coors (TAP) delivered earnings and revenue surprises of 7.69% and -3.75%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Why the Earnings Surprise Streak Could Continue for Molson Coors (TAP)
by Zacks Equity Research
Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Newell (NWL) is Poised to Beat Earnings Estimates in Q4
by Zacks Equity Research
Newell's (NWL) Transformation plan, including the sale of non-core assets, aid bottom-line performance in recent quarters.
Can PepsiCo (PEP) Retain Positive Earnings Trend in Q4?
by Zacks Equity Research
PepsiCo (PEP) gains from strong revenue growth in international division and a strong snacking business. But, soft CSD trends, currency headwinds and higher costs cannot be ignored.
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
As the marijuana industry gets more complex, check out the Zacks Market Edge Podcast where host Tracey Ryniec